Mar 1, 2025 01:24PM RVNC DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors to Secure Counsel Before Important March 4 Deadline in Securities Class Action - RVNC

Feb 7, 2025 03:47PM Crown Laboratories Completes Acquisition of Revance Therapeutics

Feb 6, 2025 08:40AM Crown Laboratories announces closing of acquisition of Revance Therapeutics

Jan 30, 2025 10:47AM Mizuho Reiterates Neutral Rating on Revance Therapeutic (RVNC)

Jan 30, 2025 10:47AM Mizuho Reiterates Neutral Rating on Revance Therapeutic (RVNC)

Jan 27, 2025 04:00PM RVNC INVESTORS: Kirby McInerney LLP Reminds Revance Therapeutics, Inc. Investors of Important Deadline and Encourages Investors to Contact the Firm

Jan 22, 2025 04:50AM Revance Therapeutic (RVNC) PT Raised to $3.65 at Mizuho

Jan 21, 2025 08:03AM Dermata (DRMA) and Revance (RVNC) Enter Clinical Trial Collaboration Agreement for the Topical Application of Xyngari with Daxxify

Jan 21, 2025 08:00AM Dermata and Revance Enter Clinical Trial Collaboration Agreement for the Topical Application of Xyngari(TM) with Daxxify(R)

Jan 15, 2025 04:00PM RVNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Jan 8, 2025 04:00PM RVNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Revance Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Jan 6, 2025 08:00PM RVNC ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Revance Therapeutics, Inc. Investors

Jan 6, 2025 09:01AM Teoxane SA Announces Superior Proposal to Acquire Revance Therapeutics (RVNC) for $3.60/sh Cash

Dec 12, 2024 10:11AM Increasing unusual put option volume: CIEN RVNC IAU ACHR UEC GALT ADBE QBTS ACMR BURL BBAI PLAY

Dec 9, 2024 10:40AM Revance Therapeutic (RVNC) PT Lowered to $3.10 at Stifel

Nov 7, 2024 05:18PM Revance Therapeutics (RVNC) Misses Q3 EPS by 10c

Sep 23, 2024 08:21AM Revance Therapeutics (RVNC) received a notice to remedy alleged material breaches

Sep 17, 2024 06:47AM Mizuho Reiterates Neutral Rating on Revance Therapeutic (RVNC)

Sep 16, 2024 02:52PM Revance Therapeutics (RVNC) January 5 puts active as share price down 16.5%

Aug 12, 2024 11:12AM William Blair Downgrades Revance Therapeutic (RVNC) to Market Perform

Aug 12, 2024 10:07AM Stifel Downgrades Revance Therapeutic (RVNC) to Hold Following Go Private Deal

Aug 12, 2024 08:00AM Crown Laboratories and Revance (RVNC) Announce Entry Into Merger Agreement

Aug 12, 2024 07:56AM Revance Therapeutics (RVNC) Halted, News Pending

Aug 8, 2024 04:32PM Revance Therapeutics (RVNC) Reports In-Line Q2 EPS, provides guidance